Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transplant Conditioning: Results of a Dose De-Escalation Trial
Titel:
Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transplant Conditioning: Results of a Dose De-Escalation Trial
Auteur:
Horan, John T. Haight, Ann Dioguardi, Jacqueline Lagerlof Brown, Clark Grizzle, Audrey Shelman, Chiani Kanter, Julie Hale, Greg Nieder, Michael Benton, Melody Kasow, Kimberly A. Abraham, Allistair Chiang, Kuang-Yueh
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 21 (2015) nr. 5 pagina's 6 p.
Jaar:
2015
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation